Suresh Kumar Rayala (Suresh K Rayala)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Venues

Journal of cellular physiology

Oncogene

This page only lists publications with an associated author ORCID identifier.

Publications

Roshni Saravanan, Vaishnavi Balasubramanian, Sandhya Sundaram, Bhawna Dev, Pavithra Vittalraj, Ravi Shankar Pitani, Gouthaman Shanmugasundaram, Suresh Kumar Rayala, Ganesh Venkatraman
Expression of cell surface zinc transporter LIV1 in triple negative breast cancer is an indicator of poor prognosis and therapy failure. Journal of cellular physiology 239 (4) (2024)
Roshni Saravanan, Vaishnavi Balasubramanian, Sandhya Sundaram, Bhawna Dev, Pavithra Vittalraj, Ravi Shankar Pitani, Gouthaman Shanmugasundaram, Suresh Kumar Rayala, Ganesh Venkatraman
Expression of cell surface zinc transporter LIV1 in triple negative breast cancer is an indicator of poor prognosis and therapy failure. Journal of cellular physiology (2024)
Roshni Saravanan, Vaishnavi Balasubramanian, Sandhya Sundaram, Bhawna Dev, Pavithra Vittalraj, Ravi Shankar Pitani, Gouthaman Shanmugasundaram, Suresh Kumar Rayala, Ganesh Venkatraman
Expression of cell surface zinc transporter LIV1 in triple negative breast cancer is an indicator of poor prognosis and therapy failure. Journal of cellular physiology 239 (4) (2024)
Roshni Saravanan, Vaishnavi Balasubramanian, Sandhya Sundaram, Bhawna Dev, Pavithra Vittalraj, Ravi Shankar Pitani, Gouthaman Shanmugasundaram, Suresh Kumar Rayala, Ganesh Venkatraman
Expression of cell surface zinc transporter LIV1 in triple negative breast cancer is an indicator of poor prognosis and therapy failure. Journal of cellular physiology 239 (4) (2024)
Roshni Saravanan, Vaishnavi Balasubramanian, Srikanth Swamy Swaroop Balamurugan, Inemai Ezhil, Zeba Afnaan, Jisha John, Sandhya Sundaram, Shanmugasundaram Gouthaman, Suresh B Pakala, Suresh Kumar Rayala, Ganesh Venkatraman
Zinc transporter LIV1: A promising cell surface target for triple negative breast cancer. Journal of cellular physiology 237 (11) (2022)
Rahul Kanumuri, Aruna Kumar Chelluboyina, Jayashree Biswal, Ravichandran Vignesh, Jaishree Pandian, Akkanapally Venu, B Vaishnavi, D J Leena, Jeyakanthan Jeyaraman, Kumaresan Ganesan, Gopala Krishna Aradhyam, Ganesh Venkatraman, Suresh Kumar Rayala
Small peptide inhibitor from the sequence of RUNX3 disrupts PAK1-RUNX3 interaction and abrogates its phosphorylation-dependent oncogenic function. Oncogene 40 (34) (2021)
Swarnalatha Beesetti, Rohan P Surabhi, Suresh Kumar Rayala, Ganesh Venkatraman
Mechanics of PAK1-A new molecular player in the arena of skin cancer. Journal of cellular physiology 234 (1) (2018)

Suresh Kumar Rayala.css-eqlu8i{font-size:small;padding-left:4px;} (Suresh K Rayala)

Publication Activity (10 Years)

Top Topics

Top Venues

Suresh Kumar Rayala (Suresh K Rayala)